Abstract
Metabolic models can be useful for rapid identification of suitable analytical targets to aid in the detection of new psychoactive substances (NPS) in human biological samples. In vitro and in vivo metabolic studies of the synthetic cannabinoid ADB-4en-PINACA were carried out using zebrafish and rat liver microsome models. Seventeen phase-I metabolites, including seventeen metabolites generated from rat liver microsomes and fourteen metabolites from zebrafish, were identified and structurally characterized by liquid chromatography–high resolution mass spectrometry. The main metabolic pathways of the phase-I metabolism included hydroxylation, N-dealkylation, amide hydrolysis, ketone formation from the t-butyl and aliphatic chains, oxidation of the N-double-bond, amide hydrolysis combined with dehydrogenation, and amide hydrolysis followed by hydroxylation, as well as dehydrogenation and N-dealkylation. Hydroxylation (M3), ketone (M10), and dihydrodiol (M15) metabolites can be recommended as metabolic markers for ADB-4en-PINACA. These findings identify the zebrafish model as a promising tool for elucidating the metabolism of NPS.
Similar content being viewed by others
REFERENCES
United Nations Office on Drugs and Crime (UNODC), World Drug Report 2013. https://www.unodc.org/wdr2013/en/nps.html Accessed July 14, 2021.
Zacca, J.J., Giudice, G.H., Souza, M.P., Caldas, L.N.B., Vieira, M.L., and Machado, A.H.L., J. Chromatogr. A, 2021, vol. 1636, 461783. https://doi.org/10.1016/j.chroma.2020.461783
Carlier, J., Diao, X., Scheidweiler, K.B., and Huestis, M.A., Clin. Chem., 2017, vol. 63, no. 5, p. 1008. https://doi.org/10.1373/clinchem.2016.267575
Lo Faro, A.F., Di Trana, A., La Maida, N., Tagliabracci, A., Giorgetti, R., and Busardò, F.P., J. Pharm. Biomed. Anal., 2020, vol. 179, 112945. https://doi.org/10.1016/j.jpba.2019.112945
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2020: Trends and Developments. https://www.emcdda.europa.eu/publications/edr/trendsdevelopments/2020_en.
United Nations Office on Drugs and Crime (UNODC), Current NPS Threats, vol. 1, March 2019. https://www.unodc.org/pdf/opioids-crisis/Current_NPS_Threats_-_Volume_I.pdf.
United Nations Office on Drugs and Crime (UNODC). The Challenge of New Psychoactive Sustances—Global SMART Programme, 2013. https://www.unodc.org/documents/scientific/NPS_Report.pdf.
Ausloos, P., Clifton, C.L., Lias, S.G., Mikaya, A.I., Stein, S.E., Tchekhovskoi, D.V., Sparkman, O.D., Zaikin, V., and Zhu, D., J. Am. Soc. Mass Spectrom., 1999, vol. 10, no. 4, p. 287. https://doi.org/10.1016/S1044-0305(98)00159-7
Castaing-Cordier, T., Ladroue, V., Besacier, F., Bulete, A., Jacquemin, D., Giraudeau, P., and Farjon, J., Forensic Sci. Int., 2021, vol. 321, 110718. https://doi.org/10.1016/j.forsciint.2021.110718
Diao, X. and Huestis, M.A., Clin. Pharmacol. Ther., 2017, vol. 101, no. 2, p. 239. https://doi.org/10.1002/cpt.534
Yue, L., Xiang, P., Shen, B., Xu, D., Song, F., and Yan, H., Drug Test. Anal., 2021, vol. 13, no. 6, p. 1223. https://doi.org/10.1002/dta.3019
Martinotti, G., Santacroce, R., Papanti, D., Elgharably, Y., Prilutskaya, M., and Corazza, O., CNS Neurol. Disord.: Drug Targets, 2017, vol. 16, no. 5, p. 567. https://doi.org/10.2174/1871527316666170413101839
Cannaert, A., Vandeputte, M., Wille, S.M.R., and Stove, C.P., Crit. Rev. Toxicol., 2019, vol. 49, no. 2, p. 95. https://doi.org/10.1080/10408444.2019.1576588
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2019b. European Drug Report 2019: Trends and Developments. http://www.emcdda.europa.eu/edr2019_en.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2018: Trends and Developments, Luxembourg: Publ. Office of the European Union, . https://www.unodc.org/documents/scientific/Regional_Overview_Europe.pdf.
Seely, K.A., Lapoint, J., Moran, J.H., and Fattore, L., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2012, vol. 39, no. 2, p. 234. https://doi.org/10.1016/j.pnpbp.2012.04.017
Grafinger, K.E., Mandhair, H.K., Broillet, A., Gertsch, J., and Weinmann, W., Forensic Toxicol., 2019, vol. 37, p. 398. https://doi.org/10.1007/s11419-019-00474-1
Wiley, J.L., Marusich, J.A., and Huffman, J.W., Life Sci., 2014, vol. 97, no. 1, p. 55. https://doi.org/10.1016/j.lfs.2013.09.011
Castaneto, M.S., Gorelick, D.A., Desrosiers, N.A., Hartman, R.L., Pirard, S., and Huestis, M.A., Drug Alcohol Depend., 2014, vol. 144, p. 12. https://doi.org/10.1016/j.drugalcdep.2014.08.005
Kemp, A.M., Clark, M.S., Dobbs, T., Galli, R., Sherman, J., and Cox, R., Am. J. Med., 2016, vol. 129, no. 3, p. 240. https://doi.org/10.1016/j.amjmed.2015.10.008
Elsohly, M.A., Gul, W., Wanas, A.S., Radwan, M.M., Life Sci., 2014, vol. 97, no. 1, p. 78. https://doi.org/10.1016/j.lfs.2013.12.212
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Understanding the 'Spice' phenomenon. http://www.emcdda.europa.eu/system/files/publications/537/Spice-Thematic-paper-final-version.pdf.
Pertwee, R.G., Br. J. Pharmacol., 2008, vol. 153, no. 2, p. 199. https://doi.org/10.1038/sj.bjp.0707442
Hill, S.L., Najafi, J., Dunn, M., Acheampong, P., Kamour, A., Grundlingh, J, Blain, P.G., and Thomas, S.H.L., Clin. Toxicol. (Phila), 2016, vol. 54, no. 8, p. 638. https://doi.org/10.1080/15563650.2016.1190980
Tait, R.J., Caldicott, D., Mountain, D., Hill, S.L., and Lenton, S., Clin. Toxicol. (Phila), 2016, vol. 54, no. 1, p. 1. https://doi.org/10.3109/15563650.2015.1110590
Fantegrossi, W.E., Moran, J.H., Radominska-Pandya, A., and Prather, P.L., Life Sci., 2014, vol. 97, no. 1, p. 45. https://doi.org/10.1016/j.lfs.2013.09.017
Hermanns-Clausen, M., Kneisel, S., Szabo, B., and Auwärter, V., Addiction, 2013, vol. 108, no. 3, p. 534. doi. 2012. 04078.xhttps://doi.org/10.1111/j.1360-0443
Abouchedid, R., Hudson, S., Thurtle, N., Yamamoto, T., Ho, J.H., Bailey, G., Wood, M., Sadones, N., Stove, C.P., Dines, A., Archer, J.R.H., Wood, D.M., and Dargan, P.I., Clin. Toxicol. (Phila), 2017, vol. 55, no. 5, p. 338. https://doi.org/10.1080/15563650.2017.1287373
Adamowicz, P., Forensic Sci. Int., 2016, vol. 261, e5. https://doi.org/10.1016/j.forsciint.2016.02.024
Cooper, Z.D., Curr. Psychiatry Rep., 2016, vol. 18, no. 5, p. 52. https://doi.org/10.1007/s11920-016-0694-1
Lin, H., Zeng, X., Wang, Q., Yinnan, L., Bin, S., Ying, W., and Wang, H., Forensic Toxicol., 2019, vol. 38, no. 1, p. 216. https://doi.org/10.1007/s11419-019-00510-0
Diao, X. and Huestis, M.A., Front. Chem., 2019, vol. 7, 109. https://doi.org/10.3389/fchem.2019.00109
Thomsen, R., Nielsen, L.M., Holm, N.B., Rasmussen, H.B., and Linnet, K., Drug Test. Anal., 2015, vol. 7, no. 7, p. 565. https://doi.org/10.1002/dta.1731
Kong, T.Y., Kim, J.H., Kim, D.K., and Lee, H.S., Arch. Pharm. Res., 2018, vol. 41, no. 7, p. 691. https://doi.org/10.1007/s12272-018-1055-x
Richter, L.H.J., Maurer, H.H., and Meyer, M.R., Toxicol. Lett., 2017, vol. 280, p. 142. https://doi.org/10.1016/j.toxlet.2017.07.901
Kronstrand, R., Norman, C., Vikingsson, S., Biemans, A., Crespo, B.V., Edwards, D., Fletcher, D., Gilbert, N., Persson, M., Reid, R., Semenova, O., Al Teneiji, F., Wu, X., Dahlén, J., NicDaéid, N., Tarbah, F., Sutcliffe, O.B., McKenzie, C., and Gréen, H., Drug Test. Anal., 2022, vol. 14, no. 4, p. 634. https://doi.org/10.1002/dta.3203
Goldsmith, P., Curr. Opin. Pharmacol., 2004, vol. 4, no. 5, p. 504. https://doi.org/10.1016/j.coph.2004.04.005
Bruni, G., Rennekamp, A.J., Velenich, A., McCarroll, M., Gendelev, L., Fertsch, E., Taylor, J., Lakhani, P., Lensen, D., Evron, T., Lorello, P.J., Huang, X.-P., Kolczewski, S., Carey, G., Caldarone, B.J., Prinssen, E., Roth, B.L., Keiser, M.J., Peterson, R.T., and Kokel, D., Nat. Chem. Biol., 2016, vol. 12, no. 7, p. 559. https://doi.org/10.1038/nchembio.2097
Anderson, J.L., Carten, J.D., and Farber, S.A., Methods Cell. Biol., 2011, vol. 101, p. 111. https://doi.org/10.1016/B978-0-12-387036-0.00005-0
Bresolin, T., de Freitas, R.M., and Celso Dias Bainy, A., Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol., 2005, vol. 140, nos. 3–4, p. 403. https://doi.org/10.1016/j.cca.2005.04.003
Jones, H.S., Panter, G.H., Hutchinson, T., and Chipman, K.J., Toxicology, 2008, vol. 253, nos. 1–3, p. 12. https://doi.org/10.1016/j.tox.2008.07.011
de Souza Anselmo, C., Sardela, V.F., Matias, B.F., de Carvalho, A.R., de Sousa, V.P., Pereira, H.M.G., and de Aquino Neto, F.R., Drug Test. Anal., 2017, vol. 9, nos. 11–12, p. 1685. https://doi.org/10.1016/j.tox.2008.07.011
Truver, M.T., Watanabe, S., Åstrand, A., Vikingsson, S., Green, H., Swortwood, M.J., and Kronstrand, R., Drug Test. Anal., 2020, vol. 12, no. 1, p. 127. https://doi.org/10.1002/dta.2688
Krotulski, A.J., Mohr, A.L.A., Kacinko, S.L., Fogarty, M.F., Shuda, S.A., Diamond, F.X., Kinney, W.A., Menendez, M.J., and Logan, B.K., J. Forensic Sci., 2019, vol. 64, no. 5, p. 1451. https://doi.org/10.1111/1556-4029.14101
Haschimi, B., Mogler, L., Halter, S., Giorgetti, A., Schwarze, B., Westphal, F., Fischmann, S., and Auwärter, V., Drug Test. Anal., 2019, vol. 11, no. 9, p. 1377. https://doi.org/10.1002/dta.2666
Lie, W., Cheong, E.J.Y., Goh, E.M.L., Moy, H.Y., Cannaert, A., Stove, C.P., and Chan, E.C.Y., Arch. Toxicol., 2021, vol. 95, no. 2, p. 489. https://doi.org/10.1007/s00204-020-02948-3
Yeter, E.O. and Yeter, O., J. Anal. Toxicol., 2021, vol. 44, no. 9, p. 976. https://doi.org/10.1093/jat/bkaa017
Watanabe, S., Vikingsson, S., Åstrand, A., Gréen, H., and Kronstrand, R., AAPS J., 2019, vol. 22, no. 1, p. 13. https://doi.org/10.1208/s12248-019-0381-3
Wohlfarth, A., Castaneto, M.S., Zhu, M., Pang, S., Scheidweiler, K.B., Kronstrand, R., and Huestis, M.A., AAPS J., 2015, vol. 17, p. 660. https://doi.org/10.1208/s12248-015-9721-0
Castaneto, M., Wohlfarth, A., Pang, S., Zhu, M., Scheidweiler, K.B., Kronstrand, R., and Huestis, M.A., Forensic Toxicol., 2015, vol. 33, p. 295. https://doi.org/10.1002/dta.2659
Carlier, J., Diao, X., Wohlfarth, A., Scheidweiler, K., and Huestis, M.A., Curr Neuropharmacol., 2017, vol. 15, no. 5, p. 682. https://doi.org/10.2174/1570159X15666161108123419
Richter, L.H.J., Maurer, H.H., and Meyer, M.R., Drug Test. Anal., 2019, vol. 11, no. 2, p. 305. https://doi.org/10.1002/dta.2493
Yeter, O. and Ozturk, Y.E., Drug Test. Anal., 2019, vol. 11, no. 6, p. 847. https://doi.org/10.1002/dta.2566
Sohlenius-Sternbeck, A.K., Chelpin, H.V., Orzechowski, A., and Halldin, M.M., Drug Metab. Dispos., 2000, vol. 28, no. 6, p. 695.
Diao, X., Deng, P., Xie, C., Li, X., Zhong, D., Zhang, Y., and Chen, X., Drug Metab. Dispos., 2013, vol. 41, no. 2, p. 430. https://doi.org/10.1124/dmd.112.04
Funding
This work was supported by the Science and Technology Commission of Shanghai Municipality (nos. 19ZR1458800, 21DZ2270800, and 19DZ2292700), the National Natural Science Foundation of China (no. 81871531).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Xinze Liu, Liu, W., Xiang, P. et al. Metabolism of ADB-4en-PINACA in Zebrafish and Rat Liver Microsomes Determined by Liquid Chromatography–High Resolution Mass Spectrometry. J Anal Chem 77, 1036–1046 (2022). https://doi.org/10.1134/S1061934822080184
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934822080184